Abstract
Enhancement of CCNU cytotoxicity by misonidazole (MISO) was studied in three tumours and two normal tissues in the mouse. The 3 experimental tumours (SCCVII/St, EMT6 and KHT) showed very different sensitivities to CCNU alone, but MISO enhanced the cell killing in ech case. The effect was not always dose-modifying, so that the CCNU dose range for the greatest enhancement was different in each of the tumours. In all 3 tumours, enhancement increased with dose of MISO. The effect on two normal tissues, marrow (CFU-S) and testis (spermatogonia), was also investigated. Enhancement of marrow toxicity could be demonstrated only at CCNU doses greater than 12.5 mg/kg, so that at lower CCNU doses there was a therapeutic gain equal to the tumour enhancement ratio. The spermatogonia effect, however, showed enhancement by MISO similar to that seen in the tumours at all CCNU doses up to 20 mg/kg.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Hirst, D., Brown, J. & Hazlehurst, J. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain. Br J Cancer 46, 109–116 (1982). https://doi.org/10.1038/bjc.1982.172
Issue Date:
DOI: https://doi.org/10.1038/bjc.1982.172
This article is cited by
-
Oncolytic activity of HF10 in head and neck squamous cell carcinomas
Cancer Gene Therapy (2020)
-
Immune-relevant aspects of murine models of head and neck cancer
Oncogene (2019)
-
Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis
Gene Therapy (2002)
-
Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors
Cancer Chemotherapy and Pharmacology (1987)
-
Treatment of malignant gliomas in adults with BCNU plus metronidazole
Journal of Neuro-Oncology (1984)